Skip to main content
Year archive

SHIELD THERAPEUTICS PLC — 2018 filings

All 31 regulatory filings released by SHIELD THERAPEUTICS PLC (STX) in 2018, sourced directly from the official regulator.

31 Filings
2018 Period
2018 filings (31)
Filing Released Lang
US New Drug Application PDUFA date for Feraccru
Regulatory Filings
2018-12-13 English
UK launch of Feraccru® by Norgine
Regulatory Filings
2018-12-05 English
New Drug Application for Feraccru®
Regulatory Filings
2018-12-03 English
Holding(s) in Company
Major Shareholding Notification
2018-11-09 English
Holding(s) in Company
Major Shareholding Notification
2018-11-08 English
Notification Of Major Holdings
Major Shareholding Notification
2018-10-01 English
Submission of an NDA for Feraccru® with the FDA
Regulatory Filings
2018-10-01 English
Director/PDMR Shareholding
Director's Dealing
2018-09-24 English
Holding(s) in Company
Major Shareholding Notification
2018-09-24 English
AEGIS-H2H Completion of Recruitment
Legal Proceedings Report
2018-09-13 English
Appointment of Non-Executive Director
Regulatory Filings
2018-07-26 English
Holdings in Company
Major Shareholding Notification
2018-07-09 English
Holdings in Company
Major Shareholding Notification
2018-07-09 English
Data from real-world clinical use of Feraccru
Regulatory Filings
2018-06-28 English
Positive top-line results from AEGIS-PAED PK study
Earnings Release H2 2018
2018-06-14 English
Directorate Change
Regulatory Filings
2018-06-05 English
2017 Annual Report and 2018 AGM Notice
AGM Information
2018-06-05 English
Grant of share options
Remuneration Information
2018-05-15 English
Holding(s) in Company
Major Shareholding Notification
2018-05-04 English
Holding(s) in Company
Major Shareholding Notification
2018-05-03 English
Price Monitoring Extension
Regulatory Filings
2018-05-02 English
Preliminary Results for the Year Ended 31 Dec 17
Earnings Release FY 2017
2018-04-11 English
Appointment of Non-Executive Director
Board/Management Information
2018-04-06 English
Results of Pre-Submission Meeting with FDA
Regulatory Filings
2018-04-06 English
Broadening of Feraccru indication
Regulatory Filings
2018-03-27 English
Update on the AEGIS-CKD study
Regulatory Filings
2018-03-16 English
Receives CHMP positive opinion on Feraccru®
Regulatory Filings
2018-02-23 English
Business and Trading Update
Regulatory Filings
2018-02-22 English
Top-line results from Feraccru Phase III study
Earnings Release FY 2017
2018-02-05 English
Notice of Results
Report Publication Announcement
2018-01-29 English
Grant of share options
Remuneration Information
2018-01-25 English